Johnson, A. G., Ruiz, J., Hughes, R., Page, B. R., Isom, S., Lucas, J. T., … Chan, M. D. (2015). Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget, 6(22), 18945–18955. https://doi.org/10.18632/oncotarget.4153

Johnson, Adam G., Jimmy Ruiz, Ryan Hughes, Brandi R. Page, Scott Isom, John T. Lucas, Emory R. McTyre, et al. “Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases.” Oncotarget 6, no. 22 (August 7, 2015): 18945–55. https://doi.org/10.18632/oncotarget.4153.

Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, et al. Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget. 2015 Aug 7;6(22):18945–55.

Johnson, Adam G., et al. “Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases.” Oncotarget, vol. 6, no. 22, Impact Journals, LLC, Aug. 2015, pp. 18945–55. Crossref, doi:10.18632/oncotarget.4153.

Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD. Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget. Impact Journals, LLC; 2015 Aug 7;6(22):18945–18955.